Hospitalization Utilization Metric After Major Oncologic Head and Neck Surgery With Microvascular Free Flap
Otolaryngology–Head and Neck Surgery · 17.08.2026
DOI: 10.1002/ohn.70377 ↗Kurz gefasst
Fachartikel in der Zeitschrift Otolaryngology–Head and Neck Surgery, online erschienen am 17.08.2026. Verfasst von Nana-Hawwa Abdul-Rahman und 6 weiteren Autor:innen. Beteiligte Einrichtung: University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA. Hauptthemen laut MEDLINE: Free Tissue Flaps, Head and Neck Neoplasms, Length of Stay, Hospitalization. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
The primary length of stay (PLOS) metric fails to capture added time, costs, and reduced patient quality of life (QOL) associated with readmissions. To address these limitations, we propose a novel metric, the hospitalization utilization metric (HUM), which integrates PLOS and readmission LOS (RLOS). Study Design Retrospective review of 626 head and neck microvascular free flap (MVFF) cases from August 2019 to May 2024.
Setting
University of Pittsburgh Medical Center.
Methods
Main outcome measure was HUM, calculated as total length of stay (TLOS) (TLOS = [PLOS + RLOS]/60 days). High HUM, determined by median split, was >0.18.
Results
Our 626‐patient cohort averaged 62.7 ± 11.9 years old. The majority of patients were male (68.2%), white (92.0%), with advanced tumors (III/IV: 74.1%), and public insurance (63.1%). The median (interquartile range [IQR]) PLOS was 9 (7‐14), median (IQR) HUM was 0.18 (0.13‐0.28), and the rate of 60‐day re‐presentation/readmission was 34.3%. Multivariable logistic regression identified postoperative complications ( β : .08, P < .001; β : 4.44, P < .001, respectively) and private insurance ( β : −.04, P < .02; −2.71, P < .01) as predictive factors associated with both higher HUM and PLOS (>9 days), respectively. Return to intensive care unit (ICU) ( β : .08, P < .003) and duration of surgery ( β : .005, P < .048) were independently associated with higher HUM, although both effect sizes are relatively small. Kaplan‐Meier survival curves revealed that higher HUM ( P = .030) but not PLOS ( P = .098) was associated with worse survival 1 year postoperatively.
Conclusion
HUM provides a comprehensive assessment of healthcare utilization compared to PLOS and re‐presentation alone and may be a practical surrogate for patient QOL and healthcare costs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
- Department of Otolaryngology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
ORCID-Profile: Nana-Hawwa Abdul-Rahman, Shaum Sridharan, Carl H Snyderman
Zitieren
APA
Abdul-Rahman, N. H., Tang, A., Balogun, Z., Harris, A., Sridharan, S., Spector, M. E., & Snyderman, C. H. (2026). Hospitalization Utilization Metric After Major Oncologic Head and Neck Surgery With Microvascular Free Flap. Otolaryngology–Head and Neck Surgery. https://doi.org/10.1002/ohn.70377
Vancouver
Abdul-Rahman NH, Tang A, Balogun Z, Harris A, Sridharan S, Spector ME, et al. Hospitalization Utilization Metric After Major Oncologic Head and Neck Surgery With Microvascular Free Flap. Otolaryngology–Head and Neck Surgery. 2026. doi:10.1002/ohn.70377
BibTeX
@article{AbdulRahman2026,
author = {Abdul-Rahman, Nana-Hawwa and Tang, Anthony and Balogun, Zainab and Harris, Alexandria and Sridharan, Shaum and Spector, Matthew E and Snyderman, Carl H},
title = {Hospitalization Utilization Metric After Major Oncologic Head and Neck Surgery With Microvascular Free Flap},
journal = {Otolaryngology–Head and Neck Surgery},
year = {2026},
doi = {10.1002/ohn.70377}
}
EUVIMED